Cambridge - Healthtech · 2016-08-09 · December 8-9, 2016 • Boston, MA PepTalk-The Protein Science Week January 9-13, 2017 • San Diego, CA Optimizing Biologics Formulation Development

Cambridge Healthtech InstituteYour Life Science Network

RESEARCH • COLLABORAT ION • ADVANCEMENT

Cambridge Innovation Institute

Conference & Course CatalogSeptember 2016 – February 2017

CHI is a division of

2 | Cambridge Healthtech Institute

For over 20 years, Cambridge Healthtech Institute has developed more than 800 conferences, which have attracted over 60,000 attendees from around the world. CHI is the industry leader in offering quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life science industry. Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation.

Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, Drug Discovery & Development, IT and Informatics, Chemistry, Diagnostics & Safety, and Business.

For a comprehensive listing and detailed information about our products and services, please visit: healthtech.com.

About Cambridge Healthtech Institute

Follow us

TABLE OF CONTENTS

CONFERENCE SERIESBiological Therapeutic Products ...................................................... 4Biomarkers and Diagnostics ........................................................... 4Bioprocess and Manufacturing ....................................................... 5Clinical Trials & Translational Medicine ............................................ 6Chemistry ....................................................................................... 6BioPharmaceutical Strategy ............................................................ 6Drug Discovery & Development ..................................................... 7Drug Targets .................................................................................... 7Genomics ........................................................................................ 8Healthcare ....................................................................................... 8Informatics and IT ........................................................................... 9Therapeutic Indications ................................................................... 9Technology and Tools for Life Sciences ..........................................10

CONFERENCES BY DATE WITH DETAIL ....................................11-13

SHORT COURSE SCHEDULE .................................................... 14-15

CUSTOMER SERVICEPamela GerardiDirector of Customer ServiceE: [email protected] | T: 781-972-5409

Kris WatermanSr. Customer Service RepresentativeE: [email protected] | T: 781-972-5413

Rose LaRaiaCustomer Service RepresentativeE: [email protected] | T: 781-972-5400

MARKETINGJim MacNeilVice President of MarketingE: [email protected] | T: 781-972-5441

Rich HandySenior Director of MarketingE: [email protected] | T: 781-972-5456

SPONSOR & EXHIBIT SALESAngela ParsonsVice President of Business DevelopmentE: [email protected] | T: 781-972-5467

Carol DinersteinDirector, Business DevelopmentE: [email protected] | T: 781-972-5471

GROUP SALES David CunninghamDirector, Inside SalesE: [email protected] | T: 781-972-5472

GRAPHICSThomas NortonDesign DirectorE: [email protected] | T: 781-972-5440

PRODUCTIONEdel O’ Regan, Ph.D.Vice President of ProductionE: [email protected] | T: 781-972-5423

Christina LinghamExecutive Director of ConferencesE: [email protected] | T: 781-972-5464

Mary Ann BrownExecutive Director of ConferencesE: [email protected] | T: 781-972-5497

Julia Boguslavsky Executive Director of ConferencesE: [email protected] | T: 760-732-3139

Micah LiebermanExecutive Director of ConferencesE: [email protected] | T: 541-482-4709

CONTACT US

@CHI_Healthtech

linkedin.com/company/cambridge-healthtech-institute

youtube.com/user/cambridgehealthtech

Cambridge Healthtech Institute 250 First Avenue, Suite 300 | Needham, MA 02494

T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288

F: (781) 972-5425

September 2016 – February 2017 | 3

2016 KEY EVENTS

2017 KEY EVENTS

LIFE SCIENCE

MEDIALIBRARY

Continue Your Education with CHI’s Digital CoursesNavigate, pause, rewind and listen to recorded sessions in a multimedia presentation. Visit CHI’s Life Science Media Library to view over 120 digital courses recorded at our most successful events. Formats available: Digital Download | On Demand | DVD

Healthtech.com/MediaLibraryOrder Today

September 19-22, 2016Westin Boston WaterfrontBoston, MADiscoveryonTarget.com

The Essential Protein Engineering SummitEUROPE

October 31-November 4, 2016EPIC SANA Lisboa HotelLisbon, PortugalPEGSummitEurope.com

January 9-13, 2017Hilton San Diego BayfrontSan Diego, CACHI-PepTalk.com

Summit for Clinical Trials Ops ExecutivesJanuary 24-26, 2017Hyatt Regency MiamiMiami, FLSCOPESummit.com

The Essential Protein Engineering SummitBOSTON

May 1-5, 2017Seaport World Trade CenterBoston, MA

PEGSummit.com

May 2-4, 2017Marriott Philadelphia DowntownPhiladelphia, PABiomarkerWorldCongress.com

February 19-24, 2017Moscone North Convention CenterSan Francisco, CATriConference.com

April 24-26, 2017Sheraton San Diego Hotel & MarinaSan Diego, CADrugDiscoveryChemistry.com

May 23-25, 2017Seaport World Trade CenterBoston, MABio-ITWorldExpo.com

June 13-15, 2017Westin Copley PlaceBoston, MAWorldPreclinicalCongress.com


Conferences by Series

Biological Therapeutic Products

The Immuno-Oncology Summit August 29 - Sept. 2, 2016 • Boston, MA

Adoptive T Cell Therapy September 1-2, 2016 • Boston, MA

Biomarkers for Immuno-OncologySeptember 1-2, 2016 • Boston, MA

Clinical Trials for Cancer ImmunotherapySeptember 1-2, 2016 • Boston, MA

NK Cell-Based Cancer ImmunotherapySeptember 19-20, 2016 • Boston, MA

Antibodies Against Membrane Protein Targets - Part 1September 20-21, 2016 • Boston, MA

Targeting Cardio-Metabolic DiseasesSeptember 20-21, 2016 • Boston, MA

GPCR-Based Drug Discovery - Part 2September 21-22, 2016 • Boston, MA

Antibodies Against Membrane Protein Targets - Part 2September 21-22, 2016 • Boston, MA

PEGS KoreaSeptember 20-22, 2016 • Seoul, Korea

Engineering for Novel BiotherapeuticsSeptember 20-22, 2016 • Seoul, Korea

Cancer ImmunotherapySeptember 20-22, 2016 • Seoul, Korea

Immunogenicity & Bioassay SummitOctober 26-28, 2016 • Baltimore, MD

Immunogenicity Assessment & Clinical RelevanceOctober 26-27, 2016 • Baltimore, MD

Immunogenicity Prediction and ControlOctober 27-28, 2016 • Baltimore, MD

Optimizing Bioassays for BiologicsOctober 27-28, 2016 • Baltimore, MD

PEGS EuropeOct. 31 - Nov. 4, 2016 • Lisbon, Portugal

Novel Immunotherapy StrategiesOct. 31 - Nov. 1, 2016 • Lisbon, Portugal

Optimisation & DevelopabilityOct. 31 - Nov. 1, 2016 • Lisbon, Portugal

Display of AntibodiesOct. 31 - Nov. 1, 2016 • Lisbon, Portugal

Engineering Next-Generation Antibody-Drug ConjugatesOct. 31 - Nov. 1, 2016 • Lisbon, Portugal

Advancing Bispecifics and Combination Therapy to the ClinicNovember 2-3, 2016 • Lisbon, Portugal

Optimising Expression Platforms November 2-3, 2016 • Lisbon, Portugal

Analytical Characterisation of BiotherapeuticsNovember 2-3, 2016 • Lisbon, Portugal

Engineering AntibodiesNovember 2-3, 2016 • Lisbon, Portugal

Engineering BispecificsNovember 3-4, 2016 • Lisbon, Portugal

Novel Therapies for Cancer and Emerging TargetsNovember 3-4, 2016 • Lisbon, Portugal

Protein Aggregates & ParticlesNovember 3-4, 2016 • Lisbon, Portugal

Protein Purification TechnologiesNovember 3-4, 2016 • Lisbon, Portugal

Preclinical Models for Cancer Immunotherapy and CombinationsNovember 14-15, 2016 • Lisbon, Portugal

Antibacterial DiscoveryDecember 7-8, 2016 • Boston, MA

DNA- and RNA-Based VaccinesDecember 6, 2016 • Boston, MA

ImVacS - Immunization and Vaccine SummitDecember 7-9, 2016 • Boston, MA

Advances in Vaccine TechnologiesDecember 7-8, 2016 • Boston, MA

Vaccine AdjuvantsDecember 8-9, 2016 • Boston, MA

PepTalk-The Protein Science WeekJanuary 9-13, 2017 • San Diego, CA

Optimizing Biologics Formulation DevelopmentJanuary 9-10, 2017 • San Diego, CA

Engineering Next-Generation Cancer ImmunotherapiesJanuary 9-10, 2017 • San Diego, CA

Recombinant Protein TherapeuticsJanuary 9-10, 2017 • San Diego, CA

Characterization of BiotherapeuticsJanuary 9-10, 2017 • San Diego, CA

Single-Use Technologies and Continuous ProcessingJanuary 9-10, 2017 • San Diego, CA

Protein Purification and RecoveryJanuary 10-11, 2017 • San Diego, CA

Antibody-Drug ConjugatesJanuary 10-11, 2017 • San Diego, CA

Recombinant Protein Expression and ProductionJanuary 10-11, 2017 • San Diego, CA

Enhancing Antibody Binding and SpecificityJanuary 10-11, 2017 • San Diego, CA

Detection and Characterization of Particulates and ImpuritiesJanuary 10-11, 2017 • San Diego, CA

Extractables and LeachablesJanuary 11-12, 2017 • San Diego, CA

Higher-Throughput Protein Production and CharacterizationJanuary 12-13, 2017 • San Diego, CA

Protein Aggregation and Emerging Analytical ToolsJanuary 12-13, 2017 • San Diego, CA

Bispecific Antibody TherapeuticsJanuary 12-13, 2017 • San Diego, CA

Optimizing Expression PlatformsJanuary 12-13, 2017 • San Diego, CA

Emerging Technologies for Antibody DiscoveryJanuary 12-13, 2017 • San Diego, CA

Bioprocess AnalyticsJanuary 12-13, 2017 • San Diego, CA

Molecular Med Tri-Con February 19-24, 2017 • San Francisco, CA

Translational Models in Oncology and Immuno-Oncology February 20-22, 2017 • San Francisco, CA

Biomarkers for Cancer ImmunotherapyFebruary 23-24, 2017 • San Francisco, CA



The Immuno-Oncology SummitAugust 29 - Sept. 2, 2016 • Boston, MA

Clinical Trials for Cancer ImmunotherapySeptember 1-2, 2016 • Boston, MA

Leaders in BioBanking CongressSeptember 7-9, 2016 • Baltimore, MD

Targeting Ocular DisordersSeptember 20-21, 2016 • Boston, MA

Targeting the Microbiome - Part 2September 21-22, 2016 • Boston, MA

Immunogenicity Assessment & Clinical RelevanceOctober 26-27, 2016 • Baltimore, MD

Preclinical Models for Cancer Immunotherapy and CombinationsNovember 14-15, 2016 • Lisbon, Portugal

Advances in Prenatal DiagnosticsNov. 29 - Dec. 1, 2016 • Cambridge, MA

Reproductive Genetic DiagnosticsDecember 1-2, 2016 • Cambridge, MA

Antibacterial DiscoveryDecember 7-8 • Boston, MA


Managing Precision Medicine TrialsJanuary 24-25, 2017 • Miami, FLSample, Lab and Diagnostic Services in Clinical TrialsJanuary 25-26, 2017 • Miami, FL

Molecular Medicine Tri-ConFebruary 19-24, 2017 • San Francisco, CA

PCR & NGS-Based Molecular DiagnosticsFebruary 20-22, 2017 • San Francisco, CA

Genomic Sample Prep, Biomarker Assay Development and ValidationFebruary 20-22, 2017 • San Francisco, CA

Digital PathologyFebruary 20-22, 2017 • San Francisco, CA

Molecular DiagnosticsFebruary 20-22, 2017 • San Francisco, CA

Molecular Diagnostics for Infectious Disease February 20-22, 2017 • San Francisco, CA

Personalized Diagnostics February 20-22, 2017 • San Francisco, CA

Cancer Molecular MarkersFebruary 20-22, 2017 • San Francisco, CA

Circulating Tumor Cells and Liquid BiopsyFebruary 20-22, 2017 • San Francisco, CA

Translational Models in Oncology and Immuno-OncologyFebruary 20-22, 2017 • San Francisco, CA

Clinical NGS Diagnostics February 20-22, 2017 • San Francisco, CA

Circulating Cell-Free DNA February 23-24, 2017 • San Francisco, CA

Microbiome-Based Precision MedicineFebruary 23-24, 2017 • San Francisco, CA

Point-of-Care Diagnostics February 23-24, 2017 • San Francisco, CA

Genomic Knowledge Bases, Annotation and Interpretation February 23-24, 2017 • San Francisco, CA

Biomarkers for Cancer ImmunotherapyFebruary 23-24, 2017 • San Francisco, CA

Commercialization of Molecular Diagnostics February 23-24, 2017 • San Francisco, CA

Oncolytic Virus Immunotherapy August 29-30, 2016 • Boston, MAImmunogenicity Prediction and ControlOctober 27-28, 2016 • Baltimore, MD

Optimizing Bioassays for BiologicsOctober 27-28, 2016 • Baltimore, MD

Optimising Expression PlatformsNovember 2-3, 2016 • Lisbon, Portugal

Protein Purification TechnologiesNovember 3-4, 2016 • Lisbon, PortugalPepTalk - The Protein Science WeekJanuary 9-13, 2017 • San Diego, CA

Optimizing Biologics Formulation DevelopmentJanuary 9-10, 2017 • San Diego, CA

Recombinant Protein TherapeuticsJanuary 9-10, 2017 • San Diego, CA

Engineering Genes and HostsJanuary 9-10, 2017 • San Diego, CA


Single-Use Technologies and Continuous ProcessingJanuary 9-10, 2017 • San Diego, CA

Lyophilization and Emerging Drying TechnologiesJanuary 10-11, 2017 • San Diego, CA

Protein Purification and RecoveryJanuary 10-11, 2017 • San Diego, CA

Antibody-Drug ConjugatesJanuary 10-11, 2017 • San Diego, CA

Recombinant Protein Expression and ProductionJanuary 10-11, 2017 • San Diego, CA


Extractables and LeachablesJanuary 11-12, 2017 • San Diego, CA

Higher-Throughput Protein Production and CharacterizationJanuary 12-13, 2017 • San Diego, CA

Protein Aggregation and Emerging Analytical ToolsJanuary 12-13, 2017 • San Diego, CA

Bispecific Antibody TherapeuticsJanuary 12-13, 2017 • San Diego, CA

Optimizing Expression PlatformsJanuary 12-13, 2017 • San Diego, CA


Bioprocess AnalyticsJanuary 12-13, 2017 • San Diego, CA

Microbial ProductionJanuary 12-13, 2017 • San Diego, CA



Adoptive T Cell TherapySeptember 1-2, 2016 • Boston, MA

Clinical Trials for Cancer Immunotherapy September 1-2, 2016 • Boston, MA

Leaders in BioBanking Congress September 7-9, 2016 • Baltimore, MD

Strategies for Tackling Rare Genetic Diseases September 19-20, 2016 • Boston, MA

Autoimmunity - Small Molecule Approaches September 19-20, 2016 • Boston, MA

GPCR-Based Drug Discovery - Part 1 September 20-21, 2016 • Boston, MA

Gene Therapy Breakthroughs September 20-21, 2016 • Boston, MA

Targeting Cardio-Metabolic DiseasesSeptember 20-21, 2016 • Boston, MA

Translating Cancer GenomicsSeptember 21-22, 2016 • Boston, MA


Metabolomics in Drug Discovery September 21-22, 2016 • Boston, MA

Immunogenicity & Bioassay Summit October 26-28, 2016 • Baltimore, MD

Immunogenicity Assessment & Clinical Relevance October 26-27, 2016 • Baltimore, MD

Immunogenicity Prediction and Control October 27-28, 2016 • Baltimore, MD

Optimizing Bioassays for Biologics October 27-28, 2016 • Baltimore, MD

Novel Immunotherapy Strategies Oct. 31 - Nov. 1, 2016 • Lisbon, Portugal

Advancing Bispecifics and Combination Therapy to the Clinic November 2-3, 2016 • Lisbon, Portugal

Strategic Resource Management November 2-3, 2016 • Philadelphia, PA

Portfolio Management November 3-4, 2016 • Philadelphia, PA

Re-Entering Antibacterial Discovery and Development Summit December 7-9, 2016 • Boston, MA

Antibacterial Development and Market Access December 8-9, 2016 • Boston, MA

Summit for Clinical Ops Executives (SCOPE) January 24-26, 2017 • Miami, FL

Clinical Data Strategy and Analytics January 24-25, 2017 • Miami, FL

Protocol Development, Global Site Selection, Feasibility and Site Management January 24-25, 2017 • Miami, FL

Managing Late Stage Research and Observational Studies January 24-25, 2017 • Miami, FL

Enrollment Planning and Patient Recruitment January 24-25, 2017 • Miami, FL

Clinical Trial Forecasting and Budgeting January 24-25, 2017 • Miami, FL

Implementing Risk-Based Monitoring-Part 1January 24-25, 2017 • Miami, FL

Establishing an Outsourcing Strategy January 24-25, 2017 • Miami, FL

Managing Precision Medicine Trials January 24-25, 2017 • Miami, FL

Clinical Technology and Innovation January 25-26, 2017 • Miami, FL

Managing Outsourced Clinical TrialsJanuary 25-26, 2017 • Miami, FL

Implementing Risk-Based Monitoring-Part 2January 25-26, 2017 • Miami, FL

Improving Site-Study Activation and Performance January 25-26, 2017 • Miami, FL

Patient Engagement, Enrollment and Retention through Communities and Technology January 25-26, 2017 • Miami, FL

Leveraging Real World Data for Clinical and Observational Research January 25-26, 2017 • Miami, FL

Sample, Lab and Diagnostic Services in Clinical Trials January 25-26, 2017 • Miami, FL

Genomic Sample Prep, Biomarker Assay Development and ValidationFebruary 20-22, 2017

Translational Models in Oncology and Immuno-OncologyFebruary 20-22, 2017

Discovery on Target September 19-22, 2016 • Boston, MA



Targeting the Ubiquitin Proteasome System September 20-21, 2016 • Boston, MA


Targeting Histone Methyltransferases and Demethylases September 20-21, 2016 • Boston, MA

Targeting Cardio-Metabolic Diseases September 20-21, 2016 • Boston, MA

Kinase Inhibitor Discovery September 21-22, 2016 • Boston, MA


Targeting Epigenetic Readers and Chromatin Remodelers September 21-22, 2016 • Boston, MA


World Preclinical Congress - Europe November 14-16, 2016 • Lisbon, Portugal

Mastering Medicinal ChemistryNovember 14-15, 2016 • Lisbon, Portugal

Optimizing Leads and Predicting Drug ToxicityNovember 15-16, 2016 • Lisbon, Portugal

Antibacterial Discovery December 7-8, 2016 • Boston, MA

Biocatalysis and Bio-Based Chemical Production January 9-10, 2017 • San Diego, CA



Strategic Resource Management November 2-3, 2016 • Philadelphia, PA

Portfolio Management November 3-4, 2016 • Philadelphia, PA

Summit for Clinical Ops Executives (SCOPE) January 24-26, 2017 • Miami, FL

Commercialization of Molecular DiagnosticsFebruary 23-24, 2017 • San Francisco, CA


Adoptive T Cell TherapySeptember 1-2, 2016 • Boston, MA

Biomarkers for Immuno-OncologySeptember 1-2, 2016 • Boston, MA



Next-Generation Histone Deacetylase Inhibitors September 19-20, 2016 • Boston, MA


Understanding CRISPR: Mechanisms and Applications September 19-20, 2016 • Boston, MA

NK Cell-Based Cancer Immunotherapy September 19-20, 2016 • Boston, MA

Autoimmunity - Small Molecule ApproachesSeptember 19-20, 2016 • Boston, MA

Targeting the Microbiome - Part 1 September 20-21, 2016 • Boston, MA


Advances in Gene Editing and Gene Silencing - Part 1 September 20-21, 2016 • Boston, MA



Antibodies Against Membrane Protein Targets - Part 1 September 20-21, 2016 • Boston, MA


Targeting Ocular Disorders September 20-21, 2016 • Boston, MA



Translating Cancer Genomics September 21-22, 2016 • Boston, MA

Advances in Gene Editing and Gene Silencing - Part 2September 21-22, 2016 • Boston, MA


Targeting Epigenetic Readers and Chromatin RemodelersSeptember 21-22, 2016 • Boston, MA



Metabolomics in Drug DiscoverySeptember 21-22, 2016 • Boston, MA

PEGS KoreaSeptember 20-22, 2016 • Seoul, South Korea

Immunogenicity Assessment & Clinical Relevance October 26-27, 2016 • Baltimore, MD

Immunogenicity Prediction and Control October 27-28, 2016 • Baltimore, MD

Optimizing Bioassays for Biologics October 27-28, 2016 • Baltimore, MD

Optimisation & Developability Oct. 31 - Nov. 1, 2016 • Lisbon, Portugal

Display of Antibodies Oct. 31 - Nov. 1, 2016 • Lisbon, Portugal


Engineering Antibodies November 2-3, 2016 • Lisbon, Portugal

Engineering Bispecifics November 3-4, 2016 • Lisbon, Portugal

Novel Therapies for Cancer and Emerging Targets November 3-4, 2016 • Lisbon, Portugal

High-Content Analysis & 3D Screening Oct. 31 - Nov. 3, 2016 • Cambridge, MA

3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip ModelsOct. 31 - Nov. 1, 2016 • Cambridge, MA

High-Content Analysis Oct. 31 - Nov. 1, 2016 • Cambridge, MA

Phenotypic Screening November 1-2, 2016 • Cambridge, MA

Screening and Functional Analysis of 3D ModelsNovember 1-2, 2016 • Cambridge, MA


Mastering Medicinal Chemistry November 14-15, 2016 • Lisbon, Portugal

Preclinical Models for Cancer Immunotherapy and Combinations November 14-15, 2016 • Lisbon, Portugal Optimizing Leads and Predicting Drug Toxicity November 15-16, 2016 • Lisbon, Portugal

Use of CRISPR & RNAi for Drug DiscoveryNovember 15-16, 2016 • Lisbon, Portugal


ImVacS-Immunization and Vaccine Summit December 7-9, 2016 • Boston, MA

Engineering Next-Generation Cancer Immunotherapies January 9-10, 2017 • San Diego, CAEnhancing Antibody Binding and Specificity January 10-11, 2017 • San Diego, CAEmerging Technologies for Antibody DiscoveryJanuary 12-13, 2017 • San Diego, CABioprocess AnalyticsJanuary 12-13, 2017 • San Diego, CATranslational Models in Oncology and Immuno-Oncology February 20-22, 2017 • San Francisco, CANew Frontiers in CRISPR-Based Gene Editing February 23-24, 2017 • San Francisco, CAMicrobiome-Based Precision Medicine February 23-24, 2017 • San Francisco, CA



Drug TargetsSERIES



Biomarkers for Immuno-Oncology September 1-2, 2016 • Boston, MA











Advances in Gene Editing and Gene Silencing - Part 1 September 20-21, 2016 • Boston, MAGPCR-Based Drug Discovery - Part 1 September 20-21, 2016 • Boston, MA














Engineering for Novel Biotherapeutics September 20-21, 2016 • Seoul, Korea

Cancer Immunotherapy September 21-22, 2016 • Seoul, Korea







3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip ModelsOctober 31 - November 1, 2016 • Cambridge, MA


Screening and Functional Analysis of 3D ModelsNovember 1-2, 2016 • Cambridge, MA

Use of CRISPR & RNAi for Drug Discovery November 15-16, 2016 • Lisbon, Portugal


Engineering Next-Generation Cancer Immunotherapies January 9-10, 2017 • San Diego, CA

Enhancing Antibody Binding and Specificity January 10-11, 2017 • San Diego, CA


New Frontiers in CRISPR-based Gene EditingFebruary 23-24, 2017 • San Francisco, CA




Advances in Gene Editing and Gene Silencing - Part 1September 20-21, 2016 • Boston, MA

Targeting Histone Methyltransferases and Demethylases September 20-21, 2016 • Boston, MAGene Therapy Breakthroughs September 20-21, 2016 • Boston, MA






Preclinical Models for Cancer Immunotherapy and Combinations November 14-15, 2016 • Lisbon, Portugal


Plant-Based Expression and Synthetic Biology January 10-11, 2017 • San Diego, CA


Managing Precision Medicine Trials January 24-25, 2017 • Miami, FL

Sample, Lab and Diagnostic Services in Clinical Trials January 25-26, 2017 • Miami, FL

Molecular Medicine Tri-ConFebruary 19-24, 2017 • San Francisco, CA

PCR & NGS-Based Molecular DiagnosticsFebruary 20-22, 2017 • San Francisco, CA

Genomic Sample Prep, Biomarker Assay Development and ValidationFebruary 20-22, 2017• San Francisco, CA


Bioinformatics for Big DataFebruary 20-22, 2017 • San Francisco, CA

Molecular DiagnosticsFebruary 20-22, 2017 • San Francisco, CA

Molecular Diagnostics for Infectious Disease February 20-22, 2017 • San Francisco, CA

Personalized DiagnosticsFebruary 20-22, 2017 • San Francisco, CA



Clinical NGS Diagnostics February 20-22, 2017 • San Francisco, CA

New Frontiers in CRISPR-Based Gene EditingFebruary 23-24, 2017 • San Francisco, CA

Circulating Cell-Free DNAFebruary 23-24, 2017 • San Francisco, CA


Reproductive Genetic DiagnosticsDecember 1-2, 2016 • Cambridge, MA


Managing Late Stage Research and Observational Studies January 24-25, 2017 • Miami, FL

Patient Engagement, Enrollment and Retention through Communities and Technology January 25-26, 2017 • Miami, FL

Leveraging Real World Data for Clinical and Observational Research January 25-26, 2017 • Miami, FL



Converged IT Summit October 24-26, 2016 • San Diego, CA

Bioprocess Analytics January 12-13, 2017 • San Diego, CA

Summit for Clinical Ops Executives (SCOPE)January 24-26, 2017 • Miami, FL

Clinical Data Strategy and Analytics January 24-25, 2017 • Miami, FL

Clinical Technology and Innovation January 25-26, 2017 • Miami, FL

Molecular Med Tri-Con February 19-24, 2017 • San Francisco, CA

Integrated Pharma InformaticsFebruary 20-22, 2017 • San Francisco, CA

Bioinformatics for Big DataFebruary 20-22, 2017 • San Francisco, CA

Genomic Knowledge Bases, Annotation and InterpretationFebruary 23-24, 2017 • San Francisco, CA

SERIESThe Immuno-Oncology Summit August 29 - Sept. 2, 2016 • Boston, MA


Biomarkers for Immuno-Oncology September 1-2, 2016 • Boston, MA



Next-Generation Histone Deacetylase InhibitorsSeptember 19-20, 2016 • Boston, MA



















PEGS KoreaSeptember 20-22, 2016 • Seoul, Korea



Advancing Bispecifics and Combination Therapy to the Clinic November 2-3, 2016 • Lisbon, Portugal

Engineering AntibodiesNovember 2-3, 2016 • Lisbon, Portugal




Antibacterial Discovery December 7-8, 2016 • Boston, MA



New Frontiers in CRISPR-based Gene EditingFebruary 23-24, 2017 • San Francisco, CA

Microbiome-Based Precision Medicine February 23-24, 2017 • San Francisco, CA

Biomarkers for Cancer Immunotherapy February 23-24, 2017 • San Francisco, CA





Strategies for Tackling Rare Genetic DiseasesSeptember 19-20, 2016 • Boston, MA






Targeting Histone Methyltransferases and DemethylasesSeptember 20-21, 2016 • Boston, MA










Converged IT Summit October 24-26, 2016 • San Diego, CA

Novel Immunotherapy Strategies October 31 - November 1, 2016 • Lisbon, Portugal

Optimisation & Developability October 31 - November 1, 2016 • Lisbon, Portugal


Optimising Expression Platforms November 2-3, 2016 • Lisbon, Portugal

Analytical Characterisation of Biotherapeutics November 2-3, 2016 • Lisbon, Portugal



Protein Aggregates & Particles November 3-4, 2016 • Lisbon

High-Content Analysis & 3D Screening Oct. 31 - Nov. 3, 2016 • Cambridge, MA

3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip ModelsOct. 31 - Nov. 1, 2016 • Cambridge, MA

High-Content AnalysisOct. 31 - Nov. 1, 2016 • Cambridge, MA


Screening and Functional Analysis of 3D Models November 1-2, 2016 • Cambridge, MA


Optimizing Leads and Predicting Drug Toxicity November 15-16, 2016 • Lisbon, Portugal


DNA- and RNA-Based Vaccines December 6, 2016 • Boston, MA

Advances in Vaccine Technologies December 7-8, 2016 • Boston, MA

PepTalk-The Protein Science Week January 9-13, 2017 • San Diego, CA

Optimizing Biologics Formulation Development January 9-10, 2017 • San Diego, CA

Engineering Genes and Hosts January 9-10, 2017 • San Diego, CA


Lyophilization and Emerging Drying Technologies January 10-11, 2017 • San Diego, CA

Recombinant Protein Expression and Production January 10-11, 2017 • San Diego, CA


Protein Aggregation and Emerging Analytical Tools January 12-13, 2017 • San Diego, CA

Optimizing Expression Platforms January 12-13, 2017 • San Diego, CA



Leaders in Biobanking CongressSeptember 7-9, 2016 • Baltimore, MDToday, biospecimen collections are used by multiple research groups for various research aims, from basic research through clinical trials. Useful biosamples must be collected to maintain their molecular integrity for specific (or unknown) downstream analysis. Thus, the proper collection, processing, storage and tracking of biospecimens are critical components allowing researchers to better link molecular and clinical information. Cambridge Healthtech Institute’s 8th International Leaders in Biobanking Congress: Applying Biospecimen Science to Advance Biomedical Research and Patient Care addresses biospecimen science, management, and applications, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research.

Healthtech.com/Biobanking

Discovery on TargetSeptember 19-22, 2016 • Boston, MACambridge Healthtech Institute will host the 14th Annual Discovery on Target event this September 19-22, 2016 in Boston, MA. Spanning four days, the event showcases current and emerging “hot” targets for the pharmaceutical industry. Over 1,100+ attendees (from 26 countries) composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations participate annually. The 2016 event is comprised of 17 conference tracks, 1 training seminar, 6 symposia, 17 short courses, an exhibit hall of 50+ companies, 135+ posters, and dedicated networking sessions. Discovery on Target assembles an impressive group of 300+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.

DiscoveryOnTarget.com

PEGS KoreaSeptember 20-22, 2016 • Seoul, South KoreaFrom the earlier regulatory successes of Adcetris® and Kadcyla® to the recent FDA approval of Blincyto®, to the current clinical successes of Opdivo® and Keytruda®, the industry is abuzz with excitement and new hope. The successes of antibody-drug conjugates, bispecific antibodies and immunotherapy drugs and combinations are opening new doors for biotech companies to discover and develop breakthrough remedies. CHI’s 2nd Annual PEGS Korea brings these exciting developments to light by gathering the industry’s leading companies and institutions together to share their experiences from discovery to preclinical to clinical stage. Join us as we bring the event back to Seoul with even more case studies, more data, and more opportunities for collaborations.

PEGSummitKorea.com

Converged IT SummitOctober 24-26, 2016 • San Diego, CAWith research laboratories now capable of generating staggering amounts of data, the IT infrastructure required to store, move and process this information must become an integral part of strategic planning for success. The Second Annual Converged IT Summit will once again cover a broad range of topics framing the issues behind creating computational solutions for modern research methodologies. Our expanded program for 2016 will break out into two tracks, allowing in-depth exploration of both the Infrastructure and the Data Science needed to create a truly converged IT. Sessions will highlight technologies currently in use, how organizations are using them to accelerate discovery, efforts that have worked and those that have failed, organizational challenges and policies for research computing, and the art of converged infrastructure as a research tool. The Converged IT Summit is designed for professionals involved with strategic planning and implementation of IT technologies to support science. The goal is to deliver solutions to scientists that give them the freedom to discover.

ConvergedITSummit.com

Immunogenicity and Bioassay SummitOctober 26-28, 2016 • Baltimore, MDFollowing year-on-year success, CHI presents the Eighth Annual Immunogenicity and Bioassay Summit 2016: 3 conferences, FDA presenters plus 40+ additional presentations, 15+ interactive breakout round table and panel discussions, short courses, exhibit/poster hall, and networking opportunities with 250+ delegates. Immunogenicity Prediction & Control is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of immunogenicity assessment and bioassays, and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements.

ImmunogenicitySummit.com

PEGS EuropeOctober 31 - November 4, 2016 • Lisbon, PortugalPEGS Europe is the largest European event covering all aspects of protein and antibody engineering. Over the last three years, participation at PEGS Europe has grown by more than 60%, and this year will be the largest ever. With a more-focused technical program, and double the coverage of the most popular PEGS topics, the 2016 event will feature 700 attendees, 200 technical presentations, 125 scientific posters, dedicated networking opportunities, exclusive exhibit & poster-viewing hours, and interactive roundtable, breakout, and panel discussions.

PEGSummitEurope.com

Conferences by Date with Detail

Conferences by SeriesEmerging Technologies for Antibody Discovery January 12-13, 2017 • San Diego, CA

PCR and NGS-Based Molecular Diagnostics February 20-22, 2017 • San Francisco, CA

Genomic Sample Prep, Assay Development and Validation February 20-22, 2017 • San Francisco, CA

Bioinformatics for Big Data February 20-22, 2017 • San Francisco, CA

Molecular Diagnostics February 20-22, 2017 • San Francisco, CA

Molecular Diagnostics for Infectious DiseaseFebruary 20-22, 2017 • San Francisco, CA

Personalized Diagnostics February 20-22, 2017 • San Francisco, CA


Circulating Tumor Cells and Liquid Biopsy February 20-22, 2017 • San Francisco, CA

New Frontiers in CRISPR-Based Gene Editing February 23-24, 2017 • San Francisco, CA

Point-of-Care Diagnostics February 23-24, 2017 • San Francisco, CA


Commercialization of Molecular Diagnostics February 23-24, 2017 • San Francisco, CA


High-Content Analysis & 3D ScreeningOctober 31 - November 2, 2016 • Cambridge, MACambridge Healthtech Institute is pleased to bring the longest-running High-Content Analysis & 3D Screening Conference to the hub of biotech and pharmaceutical research - Cambridge, MA. Now in its 14th year, the event explores the next generation in high-content and phenotypic screening and takes it to the third dimension. The High-Content Analysis and Phenotypic Screening stream will focus on the latest advancements in HCA technologies and applications, including phenotypic and high-content screening of 3D models, HCS image analysis and modeling, screening in physiologically-relevant cellular models, and case studies and strategies for successful phenotypic drug discovery. The stream on 3D cellular models and 3D screening features the latest spheroid, organoid and organotypic cell culture, and organ-on-a-chip technologies; patient-derived tumor models and human iPSC models for drug screening; and case studies in oncology drug discovery using 3D cellular models.

HighContentAnalysis.com

Strategic Resource Management & Portfolio ManagementOctober 31 - November 4, 2016 • Philadelphia, PAAlthough investment in pharma R&D continues to increase, approval of new drugs remains relatively low. This productivity crisis presents new challenges to biopharma R&D in terms of resource management, forecasting, and capacity planning. To counteract the decline in new therapeutics and high risk of product failure, biopharma must adapt with improved performance planning, intelligent outsourcing, and new big data analytics aimed at developing strategic and flexible resource management systems. In an environment of declining revenues and uncertain commercial success, biopharma, device and R&D companies need to continuously evaluate their portfolios. Manufacturers must make tough decisions about which products and projects to pursue to optimize long-term revenue and reduce overall risk. Cambridge Healthtech Institute’s and the BioPharma Strategy Series’ 13th Annual Strategic Resource Management and 10th Annual Portfolio Management Executive Forum attracts 100+ senior R&D executives from the pharma, biotech, device, IT, public and governmental communities who share best practices in project and portfolio management, R&D innovation, decision analysis, forecasting and the improvement of operational models.

ExecutiveDecisionMaking.com

World Preclinical Congress EuropeNovember 14-16, 2016 • Lisbon, PortugalThe World Preclinical Congress Europe is a key networking event bringing together a global audience involved in preclinical research. It features conferences and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery. With the broad range of conference’s covered, the event offers a diverse cross-disciplinary environment for tackling translational challenges and sharing best practices. It’s where preclinical minds meet discovery technologies to innovate traditional drug discovery by sharing ideas, showcasing new technologies, and fostering new collaborations.

WorldPreclinicalEurope.com

Advances in Prenatal Molecular DiagnosticsNovember 29 - December 1, 2016 • Cambridge, MAThe growing acceptance and availability of cell-free DNA-based screening from maternal blood is having a dramatic impact on prenatal testing. One result has been the steady decline in the number of women choosing invasive testing, with growing shift away from karyotyping in favor of arrays, or in some cases sequencing, for analysis of these samples. The range of approaches being employed for cell-free DNA testing continues to grow, including the release of kits for in-house analysis and so-called second generation assays that provide much improved detection of sub-chromosomal anomalies. There has been a push to expand NIPT use beyond higher-risk pregnancies, as well as extending the range of genetic conditions reported from the tests, but such changes come at a price. Research into testing based on isolation of fetal cells from maternal blood has been underway for decades, and the discussion has been couched in terms of “if this approach can be commercialized”. At this meeting last year, for the first time, the conversation shifted to “when this approach is commercialized” as numerous groups reported substantial progress in achieving reliable isolation that would make this possible. Updated comparisons and examination of these issues, and the implementation of these different approaches, will again make for lively discussion and insight into where this field is headed and ways for researchers, test providers, clinicians and clinics to take these developments into consideration.

Healthtech.com/Prenatal-Diagnostics

Reproductive Genetic DiagnosticsDecember 1-2, 2016 • Cambridge, MACouples experiencing infertility or failed pregnancy can now take advantage of a number of molecular diagnostic options to determine the health and wellness of their embryos as well as their own fertility. Cambridge Healthtech Institute’s Second Annual Reproductive Genetic Diagnostics conference examines the latest in preimplantation diagnostic and screening technologies, including their applications in assessing mtDNA load; determining aneuploidy through single-gene disorders; and assessing mosaicism. The meeting will also examine the potential for non-invasive PGD by blastocentesis, being developed in response to the potential effect biopsy and vitrification may have on the development of the embryo. There will be discussion on PGD for donor eggs, such as how much or how often testing should be done. The meeting will also cover advances in CRISPR, including current research and capabilities, as well as how this technology may or may not be used in the future. New this year, special attention will be paid to molecular diagnostics for finding infertility biomarkers in sperm and the uterus.

Healthtech.com/Reproductive-Genetic-Diagnostics

Biological & Chemical Sensors SummitDecember 5-7, 2016 • La Jolla, CAEmerging technological innovations enabled by next generation sensors will define the landscape for the future commercialization of life changing products. The exponential growth of the global sensors market and the demand for next generation integrated systems is expected to reach $18 billion by 2018. Our international faculty of key industry and academic leaders will present the latest technological advancements of real-world applications within healthcare and emerging markets through our conference tracks, symposiums and tutorials. SensorsGlobalSummit.com



Re-Entering Antibacterial Drug Development SummitDecember 7-9, 2016 • Boston, MABy holding the Re-Entering Antibacterial Discovery and Development Summit, we at Cambridge Healthtech Institute are trying to contribute to the efforts to overcome the crisis of multidrug resistance, to revive the antibacterial pipeline, and to improve antimicrobial stewardship in the United States and worldwide. This Summit is designed as a forum for knowledge and opinion exchange among all stakeholders participating in discovery and development of new antibacterial agents.

AntibacterialDrugDevelopmentSummit.com

IMVACS: Immunization & Vaccine SummitDecember 7-9, 2016 • Boston, MAGlobally, immunization has proven to be the gateway to health for millions, and continued investment in vaccine development provides a measureable return in reducing the burden of disease and safeguarding human development. Today, more than ever, vaccine technology remains at the forefront of the confrontation against infectious disease. Cambridge Healthtech Institute’s Eleventh Annual Immunization and Vaccine Summit will cover a range of topics in this evolving field, including the latest advancements and applications of vaccine technologies, development of effective vaccine adjuvants, and progress in DNA- and RNA-based vaccines.

IMVACS.com

PepTalk: The Protein Science WeekJanuary 9-13, 2017 • San Diego, CAPepTalk: The Protein Science Week is one of the largest annual gatherings of protein science researchers in the world. In its 16th year, PepTalk attracts over 1,200 experts from academia, biotech and pharma who come together for one week of intensive learning and networking to discover new opportunities and promising partnerships. This event covers a wide spectrum, from upstream protein R&D science to downstream biologics. And, whether you’re a world-renowned researcher or a current graduate student, PepTalk has something to offer.

CHI-PepTalk.com

SCOPE Summit for Clinical Ops ExecutivesJanuary 24-26, 2017 • Miami, FLThe 8th Annual SCOPE Summit, taking place January 24-26, 2017 in Miami, FL, will offer three stimulating days of in-depth discussions in 13 different conferences, 6 pre-conference workshops and 2 symposia focused on issues related to each aspect of clinical trial planning and management: Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Lab Services, Precision Medicine and Biomarker-Driven Trials.

SCOPESummit.com

Molecular Medicine Tri-ConFebruary 19-24, 2017 • San Francisco, CAAttracting over 3,500 drug discovery and development professionals from over 40 countries in 2016, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology. If you are working in diagnostics and drug discovery, this is the must attend event of the year.

TriConference.com

PANIC: Practical Applications of NMR in IndustryFebruary 20-23, 2017 • Hilton Head Island, SCPractical Applications of NMR in Industry Conference (PANIC) was initiated to provide an interactive forum for discussion of the latest developments in the use of NMR for practical applications to real problems faced by scientists in industry and research institutions. The emphasis is the practicality of the solution and “getting the job done”. This forum provides a venue for presentation of practical applications, and workshops for discussion of real-world experiences relevant to current product development needs with an opportunity to share case studies to drive further development of NMR technology. Solution-state, solid-state, time-domain, and zero-field applications are all equally welcome at PANIC. PANIC also provides ample opportunity to network with peers and thought leaders from industry, regulatory, government, and academic institutions during networking receptions and breaks; engage in fruitful discussions during the poster sessions; and interact with sponsors and exhibitors.

panicNMR.com


ONE STOP SHOP AFFILIATED REPORTSCOLLECTION

for Over 1,000 Life Science Reports Spanning over 50 Research Areas

Insight Pharma Reports offers:

4 Market Data4 Pipeline Data4 Clinical Trial Data

4 Market Research4 Custom Reports4 Bundled Report Packages

For more information, contact Daniel Miller at: [email protected] or call (781) 972-5492

InsightPharmaReports.com

Just some of the Reports Available Include:

• Alzheimer’s Disease• Biomarkers & Diagnostics• BioPharma Strategy• Biosimilars & Generic Markets• Cancer Research and Therapeutics• Chemistry• Clinical Trials &

Translational Medicine

• Data Mining• Drug Discovery & Development• Health IT• Infectious Disease• Medical Devices• Multiple Sclerosis• Ocular• Pain Management• Pharmaceutical Marketing• Sequencing• Vaccines

...and many others

An Essential Collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues Driving R&D Productivity. Available through Insight Pharma Reports and our Network of Affiliated Reports.


LEADERS IN BIOBANKING CONGRESS September 7, 2016 • Baltimore, MD

IMMUNOGENICITY AND BIOASSAY SUMMITOctober 25 & 27, 2016 • Baltimore, MD

-- Managing a Viable Biobank -- Basics of Immunogenicity Testing

-- Tools for Extracting, Amplifying and Detecting Minute Amounts of -- Challenges of Immunogenicity Assessment

Circulating Nucleic Acids -- Advice on Putting Together an Integrated Summary of Immunogenicity

DISCOVERY ON TARGET -- Strategic Bioassay Design and Analysis

September 19 & 21, 2016 • Boston, MA

-- Immunology Basics for Chemists PEGS EUROPE

-- Designing Peptide Therapeutics for Specific PPIs October 31 & November 3, 2016 • Lisbon, Portugal

-- Phenotypic Screening and Chemical Probe Development -- Cancer Immunotherapy

-- Medical Dermatology Therapeutic R&D and Technical Innovation: Understanding Mechanisms, Novel Targets and Pathways & Industry Case Studies - Part One

-- Mutation and Selection Strategies beyond Affinity Optimisation

-- Designing Antibodies for Function and Low Risk of Immunogenicity

-- GPCR Structure-Based Drug Discovery -- Transient Protein Expression: A Key Tool to Enable Rapid Protein Engineering -- RNA as a Small Molecule Drug Target

-- Using IP Landscape Studied to Improve Your Confidence While Navigating a Crowded IP and Technology Space

-- Troubleshooting and Engineering of Antibody Constructs

-- Engineering of Bispecific Antibodies

-- Medical Dermatology Therapeutic R&D and Technical Innovation: Early Formulation Considerations, Utilizing New Tech for Med Derm R&D, CMC, Formulation Development and Late Stage Clinical - Part Two

-- Protein Purification Strategies: Dealing with Proteins that are Prone to Aggregate

-- Protein Aggregation: Mechanism, Characterisation and Consequences

-- Targeting of GPCRs with Monoclonal Antibodies

-- Introduction to Targeted Covalent Inhibitors HIGH CONTENT ANALYSIS & 3D SCREENING

-- Contact Lens Drug Delivery Systems October 31 - November 1, 2016 • Cambridge, MA

-- Introduction to Gene Editing -- Introduction to High-Content Phenotypic Screening

-- Convergence of Immunotherapy and Epigenetics for Cancer Treatment

-- Expert ThinkTank: How to Meet the Need for Physiologically Relevant Assays

-- Cancer Metabolism: Pathways, Targets and Clinical Updates

-- Introduction to Allosteric Modulators and Biased Ligands of GPCRs

STRATEGIC RESOURCE & PORTFOLIO MANAGEMENT

October 31 - November 1, 2016 • Philadelphia, PA

-- Functional Screening Strategies Using CRISPR and RNAi -- Project Portfolio Management Certification Master Class

-- Challenges and Opportunities in DNA Methyl Transferase (DNMT) Inhibitors as Therapeutics WORLD PRECLINICAL CONGRESS EUROPE

-- SVPs, Aggregates and Impurities: Measurement, Characterization, November 14-15, 2016 • Lisbon, Portugal

-- Humanized Mouse Models: Technology and Applications in Preclinical Assessment of Cancer ImmunotherapyPEGS KOREA

September 21, 2016 • Seoul, South Korea -- New Technologies for Improving Drug Safety Screening

-- Troubleshooting and Engineering of Antibody Constructs -- Functional Screening Strategies Using CRISPR and RNAi

CONVERGED IT SUMMITOctober 24, 2016 • San Diego, CA

RE-ENTERING ANTIBACTERIAL DISCOVERY & DEVELOPMENT SUMMIT

December 6 & 8, 2016 • Boston, MA

-- Designing Storage Solutions for Life Sciences -- From “White Powder” to Drug: The Path from Antibacterial Discovery to the Clinic -- Foundational Services for Bioinformatics in the AWS Cloud

-- Funding Opportunities for Antibacterial Research

Short Course Schedule HOLD A COURSE AT YOUR FACILITY.For more information, please contact Edel O’Regan at 781-972-5423 or email: [email protected]


IMVACS: IMMUNIZATION & VACCINE SUMMIT SCOPE: SUMMIT FOR CLINICAL OPS EXECUTIVES

December 7-9 2016 • Boston, MA January 23, 2017 • Miami, FL

-- Expert ThinkTank: Zika Vaccine Development -- Implementing Social Media, Digital Marketing and Other New Strategies for Patient Recruitment

PEPTALK: THE PROTEIN SCIENCE WEEK -- How to Implement RBM on a Budget

January 8-10, 2017 • San Diego, CA -- Clinical Trial Protocol Optimization

-- Production Challenges for Complex Biologics: ADCs, Bispecifics and Fusion Proteins

-- Managing Trials in Oncology and Immuno-Oncology

-- Developing Your Custom Strategy for Requests for Proposals (RFPs) through to Final Contract -- A Modern Approach to Biologics Formulation Development

-- A Lean Approach to Lab Management -- How to Accelerate Digital Health Innovation in Your Company

-- New Enzyme Design, Discovery and Development

-- A Lean Approach to Lab Management MOLECULAR MEDICINE TRI-CONFERENCE

-- New Enzyme Design, Discovery and Development February 19-24 2016 • San Francisco, CA

-- Ensuring Accelerated and Successful Drug Product Development of Biologics Integrated Formulation Development, Process and Packaging Design

-- Short Course Line-Up TBA

-- Next-Generation Sequencing of Antibody Libraries: Details on Experimental and Bioinformatic Methods

-- Troubleshooting and Engineering of Antibody Constructs

-- Protein Aggregation: Mechanism, Characterization and Consequences

-- Transient Protein Production in Mammalian Cells

-- Plant-Based Products: From Biosimilars to Biobetters

Short Course Schedule

• Daily and Breaking News

• Complimentary Newsletters and eBooks

• Free Industry Whitepapers, Podcasts, Market Survey Results, and Webinars

• Online Product Directory

SUBSCRIBETODAY

To learn more about Bio-IT World, Clinical Informatics News, and Diagnostics World digital advertising and lead generation programs, download the Media Kit at: www.HealthtechPublishing.com/Media-Kit

Healthtech Publishing250 First Avenue, Suite 300, Needham, MA 02494T: 781-972-5400 or toll-free in the U.S. 888-999-6288F: 781-972-5425 • www.HealthtechPublishing.com

PUBLICATIONS AVAILABLE FROM

www.Bio-ITWorld.com www.ClinicalInformaticsNews.com

Clinical Trials to the Clinic

CLINICALINFORMATICSNEWS

www.DiagnosticsWorldNews.com

Diagnostics WorldBeyond the Odyssey: Emerging Technologies in Diagnostics

CHI is a division of Cambridge Innovation Institute

CHI

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-CON, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target.

About Cambridge Healthtech InstituteYour Life Science Network

ADDITIONAL DIVISIONS OF CHI INCLUDE

healthtechpublishing.com insightpharmareports.com

knowledgefoundation.com barnettinternational.com

healthtech.com250 First Avenue, Suite 300

Needham, Massachusetts 02494

USA Phone: 781.972.5400

Documents

Cambridge - Healthtech · 2016-08-09 · December 8-9, 2016 • Boston, MA PepTalk-The Protein Science Week January 9-13, 2017 • San Diego, CA Optimizing Biologics Formulation Development